PTKFY:OTCMKTS
PT Kalbe Farma Unsponsored Indonesia ADR
US$8.50
0.00%
(0.00) 1D
10월 12일, 오전 10시 22분 9초 GMT-4 · USD
search
모든 종목 코드
| 종목 코드 | 가격 | 변동 | 변동률(%) |
|---|
insights_autoPTKFY의 주요 통계 생성 중...
시가총액
31.60조
평균 거래량
1.96천
거래량
148.00
52주 최고가
US$16.36
52주 최저가
US$7.63
베타
0.09
유통 주식수
2.34억
직원 수
1만
시가총액
31.60조
평균 거래량
1.96천
거래량
148.00
52주 최고가
US$16.36
52주 최저가
US$7.63
베타
0.09
유통 주식수
2.34억
직원 수
1만
뉴스 기사
웹 소스 및 뉴스 파트너 제공
ad-hoc-news.de
·
1시간 전
Indo Premier sees Kalbe Farma stock earnings beating estimates
ad-hoc-news.de
·
1일 전
Kalbe Farma launches IDR 500 billion buyback while Kiwoom targets Kalbe Farma stock
ad-hoc-news.de
·
1일 전
Kalbe Farma launched an IDR 500 billion buyback of Kalbe Farma stock
프로필
PT Kalbe Farma Tbk, or simply known as Kalbe, is an Indonesian pharmaceutical, healthcare and nutrition company established in 1966. The company has expanded by strategic acquisitions of pharmaceutical companies, becoming an integrated consumer health and nutrition enterprise.
The Kalbe Group has brands in the prescription drugs, OTC drugs, energy drink and nutrition products, with a distribution arm that reaches over one million outlets. Notably, the company produces misoprostol, a drug which is used to treat stomach ulcers but is also widely used in Indonesia as an illegal abortifacient.
Company brands in healthcare and pharmaceutical segments include Promag, Mixagrip, Woods, Komix, Diabetasol, Prenagen, Extra Joss and Fitbar.
Kalbe is the largest publicly listed pharmaceutical company in Southeast Asia with around US$5 billion in market capitalization and revenues of over Rp 15 trillion. The name "Kalbe" is a syllabic abbreviation of its founder's name: Khouw Lip Boen. Wikipedia
PT Kalbe Farma Unsponsored Indonesia ADR에 관한 정보